Mounjaro operates by mimicking certain hormones that regulate appetite and insulin secretion
GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Clinical Pharmacist, Drug Information Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Director, Pipeline Lisa Schweizer, PharmD, JD Director, Clinical Program Management Deputy Editor DISCLAIMER The drug pipeline is fluid
If the 2.4 mg maintenance dose is not tolerated, 1.7 mg may be used as an alternative maintenance dose
& Hagspiel, K
doi: 10.1097/JIM.0000000000000129 156 KingMRAndersonNJDeciuMGuernseyLSCundiffMHajizadehSet al
ColonBroom highlights non-GMO sourcing, vegan-friendly capsules, and cGMP-certified facilities